Company profile
Crescendo Biologics Limited is a UK company with status active founded in 2007 based in East of England.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
SH03 | Transaction MzQ3MDc2Njc5NGFkaXF6a2N4 | Paper/PDF filed
Published 20 Jun 2025 07:11
Last accounts made up date
SH01 | Transaction MzQ0NDkxOTc3MGFkaXF6a2N4
Published 26 Nov 2024 12:06
SH01 | Transaction MzQzNTI4MDc4OGFkaXF6a2N4
Published 11 Sep 2024 12:07
AP03 | Transaction MzQzNTI3NTM2NWFkaXF6a2N4
Published 11 Sep 2024 11:22
AA | Transaction MzQzMzYwODcxNWFkaXF6a2N4 | Paper/PDF filed
Published 31 Aug 2024 06:56
RP04CS01 | Transaction MzQzMTUxMjI0NGFkaXF6a2N4
Published 21 Aug 2024 11:57
MR04 | Transaction MzQzMTc0ODk0NmFkaXF6a2N4
Published 09 Aug 2024 17:46
CS01 | Transaction MzQzMTUwMzgxNmFkaXF6a2N4 | Paper/PDF filed
Published 22 Aug 2024 07:04
TM01 | Transaction MzQzMTUwODczMGFkaXF6a2N4
Published 07 Aug 2024 14:01
Company registered at Companies House
1 Aug 2015 to 31 Oct 2016
While mAb-based ADCs have shown good efficacy, there are currently only two approved by the FDA due to significant challenges associated with this product class including high production costs and off target toxicity. The Crescendo Mouse is a novel platform which generates the smallest potent human antibody fragments (Humabodies™). With a view to developi...
